valsartan capsules hard 40mg
aurobindo pharma (malta) limited vault 14, level 2, valletta waterfront, floriana frn 1913, malta - valsartan - hard capsule - valsartan 40 mg - agents acting on the renin-angiotensin system
valsartan capsules hard 80mg
aurobindo pharma (malta) limited vault 14, level 2, valletta waterfront, floriana frn 1913, malta - valsartan - hard capsule - valsartan 80 mg - agents acting on the renin-angiotensin system
valsartan capsules hard 160mg
aurobindo pharma (malta) limited vault 14, level 2, valletta waterfront, floriana frn 1913, malta - valsartan - hard capsule - valsartan 160 mg - agents acting on the renin-angiotensin system
valsartan 40mg capsules
actavis group ptc ehf revkjavikurvegi 76-78, 220 hafnarfjordur, iceland - valsartan - capsule - valsartan 40 mg - agents acting on the renin-angiotensin system
valsartan 80mg capsules
actavis group ptc ehf revkjavikurvegi 76-78, 220 hafnarfjordur, iceland - valsartan - capsule - valsartan 80 mg - agents acting on the renin-angiotensin system
valsartan 160mg capsules
actavis group ptc ehf revkjavikurvegi 76-78, 220 hafnarfjordur, iceland - valsartan - capsule - valsartan 160 mg - agents acting on the renin-angiotensin system
valsartan jubilant tablet, film coated 40mg
jubilant pharmaceuticals nv axxes business park, guldensporenpark 22 – block c, 9820 merelbeke, belgium - valsartan - film-coated tablet - valsartan 40 mg - agents acting on the renin-angiotensin system
valsartan jubilant tablet, film coated 80mg
jubilant pharmaceuticals nv axxes business park, guldensporenpark 22 – block c, 9820 merelbeke, belgium - valsartan - film-coated tablet - valsartan 80 mg - agents acting on the renin-angiotensin system
valsartan jubilant tablet, film coated 160mg
jubilant pharmaceuticals nv axxes business park, guldensporenpark 22 – block c, 9820 merelbeke, belgium - valsartan - film-coated tablet - valsartan 160 mg - agents acting on the renin-angiotensin system
valsartan -medo 160 mg
a.l. medi-market ltd. - valsartan - film coated tablets - valsartan 160 mg - valsartan - for treatment of hypertension. valsartan-medo is indicated for the treatment of heart failure (nyha class ii-iv) in patients who are intolerant of angiotensin converting enzyme inhibitors. in a controlled clinical trial valsartan-medo signicantly reduced hospitalisations for heart failure. there is no evidence that valsartan-medo provides added benefits when it is used with an adequate dose of an ace inhibitor. valsartan-medo is indicated to improve survival following myocardial infarction in clinically stable patients with signs symptoms or radiological evidence of left ventricular failure and /or with left ventricular systolic dysfunction.